"Left Atrial Appendage Occlusion and Biomarker Evaluation" (LABEL) is a single-center, prospective and observational study evaluating changes of the expression of biomarkers in eligible patients before and after percutaneous implantation of a left atrial appendage (LAA) occlusion device at mid-term follow-up.
This study will evaluate the changes of different types of biomarkers before and after successful percutaneous implantation of an LAA occlusion device. Biomarker evaluation will focus on blood derived biomarkers including neurohormones, proteins, cytokines, microRNAs and metabolomics.
Study Type
OBSERVATIONAL
Enrollment
60
University Medical Centre Mannheim
Mannheim, Baden-Wurttemberg, Germany
Biomarker levels before successful LAA occlusion device implantation
Time frame: 24 hours before intervention
Biomarker levels after successful LAA occlusion device implantation
Time frame: mid-term follow up at 6 months
Changes of biomarker expression before and after device implantation over mid-term follow-up, depending of complete, incomplete occlusion, imaging data (transesophageal echocardiography, computed tomography)
Time frame: mid-term follow up at 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.